Newbridge Financial Services Group’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Newbridge Financial Services Group’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,050	Closed	-$44K	–	1572
2022 Q1	$44K	Buy	2,050 +200	+11%	+$5.3K	0.02%	512
2021 Q4	$62K	Sell	1,850 -300	-14%	-$8.36K	0.03%	407
2021 Q3	$55K	Sell	2,150 -350	-14%	-$6.26K	0.03%	390
2021 Q2	$33K	Sell	2,500 -2,800	-53%	-$34.6K	0.02%	589
2021 Q1	$56K	Buy	5,300 +3,300	+165%	+$37.6K	0.04%	370
2020 Q4	$16K	Buy	+2,000	New	+$15.7K	0.01%	604

Other funds holding OPNT

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Newbridge Financial Services Group's OPNT Position: Q2 2022 in Review

Newbridge Financial Services Group sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2022, closing a stake of 2,050 shares — an estimated $44K sold.

Newbridge Financial Services Group first reported a position in OPNT in Q4 2020 and held it in 6 quarters. The position peaked at $62K in Q4 2021. 33 funds tracked by Wall St. Rank hold OPNT as of Q2 2022.

Newbridge Financial Services Group reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Newbridge Financial Services Group sold 2,050 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $44K.
Newbridge Financial Services Group first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Newbridge Financial Services Group's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $62K in Q4 2021.
33 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Newbridge Financial Services Group's 13F filing for Q2 2022, filed 15 Jul 2022.